Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 682342-65-0 | MDL No. : | MFCD11847617 |
Formula : | C4H2F3IN2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OUIRKYPQKWDIHQ-UHFFFAOYSA-N |
M.W : | 294.04 | Pubchem ID : | 22717671 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.24 |
TPSA : | 67.15 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.52 cm/s |
Log Po/w (iLOGP) : | 1.7 |
Log Po/w (XLOGP3) : | 2.21 |
Log Po/w (WLOGP) : | 3.51 |
Log Po/w (MLOGP) : | 1.64 |
Log Po/w (SILICOS-IT) : | 3.58 |
Consensus Log Po/w : | 2.53 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.33 |
Solubility : | 0.139 mg/ml ; 0.000472 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.25 |
Solubility : | 0.164 mg/ml ; 0.000556 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.76 |
Solubility : | 0.506 mg/ml ; 0.00172 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 349-49-5 ]
4-(Trifluoromethyl)thiazol-2-amine
Similarity: 0.79
[ 136411-21-7 ]
5-Bromo-4-(trifluoromethyl)thiazol-2-amine
Similarity: 0.69
[ 1314977-20-2 ]
(2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol
Similarity: 0.62
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.57
[ 109113-98-6 ]
6-(Trifluoromethyl)imidazo[2,1-b]thiazole
Similarity: 0.57
[ 349-49-5 ]
4-(Trifluoromethyl)thiazol-2-amine
Similarity: 0.79
[ 136411-21-7 ]
5-Bromo-4-(trifluoromethyl)thiazol-2-amine
Similarity: 0.69
[ 1314977-20-2 ]
(2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol
Similarity: 0.62
[ 59608-97-8 ]
4-(Chloromethyl)thiazol-2-amine hydrochloride
Similarity: 0.57
[ 349-49-5 ]
4-(Trifluoromethyl)thiazol-2-amine
Similarity: 0.79
[ 136411-21-7 ]
5-Bromo-4-(trifluoromethyl)thiazol-2-amine
Similarity: 0.69
[ 1314977-20-2 ]
(2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol
Similarity: 0.62
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.57
[ 109113-98-6 ]
6-(Trifluoromethyl)imidazo[2,1-b]thiazole
Similarity: 0.57
[ 349-49-5 ]
4-(Trifluoromethyl)thiazol-2-amine
Similarity: 0.79
[ 136411-21-7 ]
5-Bromo-4-(trifluoromethyl)thiazol-2-amine
Similarity: 0.69
[ 1314977-20-2 ]
(2-Amino-4-(trifluoromethyl)thiazol-5-yl)methanol
Similarity: 0.62
[ 41731-39-9 ]
2-Bromo-4-(trifluoromethyl)thiazole
Similarity: 0.57